Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (Imatrix-Cobi): A Multicenter, Phase I/II Study
Targeted Oncology(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined